King Luther Capital Management Corp increased its holdings in Colgate-Palmolive (NYSE:CL) by 0.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,579,942 shares of the company’s stock after purchasing an additional 700 shares during the period. King Luther Capital Management Corp owned 0.18% of Colgate-Palmolive worth $115,099,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of CL. Jacobi Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 125.5% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after acquiring an additional 803 shares in the last quarter. Krilogy Financial LLC raised its holdings in shares of Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after acquiring an additional 289 shares in the last quarter. Captrust Financial Advisors purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth approximately $122,000. AlphaMark Advisors LLC raised its holdings in shares of Colgate-Palmolive by 1.5% during the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after acquiring an additional 25 shares in the last quarter. Finally, Bruderman Asset Management LLC purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth approximately $126,000. 72.86% of the stock is currently owned by institutional investors.
In other news, CMO Mukul Deoras sold 7,500 shares of the stock in a transaction on Friday, November 10th. The stock was sold at an average price of $73.28, for a total transaction of $549,600.00. Following the transaction, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at approximately $3,313,501.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Stephen I. Sadove sold 20,780 shares of the stock in a transaction on Monday, November 6th. The stock was sold at an average price of $70.52, for a total value of $1,465,405.60. Following the transaction, the director now directly owns 36,268 shares in the company, valued at approximately $2,557,619.36. The disclosure for this sale can be found here. Insiders sold a total of 181,950 shares of company stock worth $13,237,385 in the last ninety days. 1.02% of the stock is currently owned by corporate insiders.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.73. The company had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. Colgate-Palmolive’s quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.73 EPS. equities research analysts expect that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.12%. The ex-dividend date of this dividend is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.
Several analysts have recently issued reports on CL shares. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price objective on the stock in a report on Monday, September 25th. SunTrust Banks raised Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price objective for the stock from $65.00 to $85.00 in a report on Wednesday, October 11th. Stifel Nicolaus set a $73.00 price objective on Colgate-Palmolive and gave the stock a “hold” rating in a report on Sunday, October 29th. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Finally, Royal Bank of Canada reaffirmed a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a report on Sunday, October 8th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $76.45.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.